NorZinc Ltd (NZC.CA) Stock Fundamental Analysis

TSX:NZC • CA66976U1049

0.03 CAD
0 (0%)
Last: Dec 15, 2022, 07:00 PM
Fundamental Rating

0

NZC gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 807 industry peers in the Metals & Mining industry. NZC may be in some trouble as it scores bad on both profitability and health. NZC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • NZC had negative earnings in the past year.
  • NZC had a negative operating cash flow in the past year.
NZC.CA Yearly Net Income VS EBIT VS OCF VS FCFNZC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -5M -10M -15M

1.2 Ratios

  • NZC has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NZC.CA Yearly ROA, ROE, ROICNZC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -50 -100 -150 -200 -250

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NZC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NZC.CA Yearly Profit, Operating, Gross MarginsNZC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 -20K -40K -60K -80K -100K

0

2. Health

2.1 Basic Checks

  • NZC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NZC has more shares outstanding
  • Compared to 1 year ago, NZC has an improved debt to assets ratio.
NZC.CA Yearly Shares OutstandingNZC.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 200M 400M 600M
NZC.CA Yearly Total Debt VS Total AssetsNZC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M

2.2 Solvency

  • NZC has an Altman-Z score of -55.34. This is a bad value and indicates that NZC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of NZC (-55.34) is worse than 85.49% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -55.34
ROIC/WACCN/A
WACC10.25%
NZC.CA Yearly LT Debt VS Equity VS FCFNZC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M

2.3 Liquidity

  • NZC has a Current Ratio of 0.14. This is a bad value and indicates that NZC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NZC has a Current ratio of 0.14. This is amonst the worse of the industry: NZC underperforms 86.15% of its industry peers.
  • A Quick Ratio of 0.14 indicates that NZC may have some problems paying its short term obligations.
  • NZC has a Quick ratio of 0.14. This is amonst the worse of the industry: NZC underperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
NZC.CA Yearly Current Assets VS Current LiabilitesNZC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

  • The earnings per share for NZC have decreased by -6.30% in the last year.
  • The Revenue for NZC has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)-6.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.52%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • NZC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.41% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3Y-13.64%
EPS Next 5Y3.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NZC.CA Yearly Revenue VS EstimatesNZC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 50K 100K 150K
NZC.CA Yearly EPS VS EstimatesNZC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2024 2025 2026 -0.01 -0.02 -0.03 -0.04 -0.05

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NZC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NZC.CA Price Earnings VS Forward Price EarningsNZC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NZC.CA Per share dataNZC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0.01 -0.01

4.3 Compensation for Growth

  • NZC's earnings are expected to decrease with -13.64% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3Y-13.64%

0

5. Dividend

5.1 Amount

  • No dividends for NZC!.
Industry RankSector Rank
Dividend Yield N/A

NorZinc Ltd

TSX:NZC (12/15/2022, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners4.06%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.72M
Revenue(TTM)N/A
Net Income(TTM)-17.57M
Analysts80
Price Target0.15 (400%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 231.71%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z -55.34
F-Score2
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)91.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3Y-13.64%
EPS Next 5Y3.41%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-37.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.12%
OCF growth 3YN/A
OCF growth 5YN/A

NorZinc Ltd / NZC.CA FAQ

What is the ChartMill fundamental rating of NorZinc Ltd (NZC.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to NZC.CA.


What is the valuation status for NZC stock?

ChartMill assigns a valuation rating of 0 / 10 to NorZinc Ltd (NZC.CA). This can be considered as Overvalued.


How profitable is NorZinc Ltd (NZC.CA) stock?

NorZinc Ltd (NZC.CA) has a profitability rating of 0 / 10.